glp-1 drugs for inflammation Health Feed Anti-inflammatory role of glucagon-like peptide

Increased appetite plays a key role in olanzapine-induced weight gain in first-episode schizophrenia patients

The Order notes that 17 cases were transferred in the original transfer order on February 2, 2024

Activation of the GLP-1 receptor decreases appetite and improves satiety, slows gastric emptying, increases glucose-dependent insulin secretion and decreases glucose-dependent glucagon secretion (Figure 2)

Read in context, it is a secondary, exploratory outcome from a Phase 2 trial whose primary endpoint, change in cerebral glucose metabolism, was negative, and whose cognitive signal was modest

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

Evidence of such side effects was evident in our latest analysis of brands to watch in 2024, where both Ducolax and Miralax made the list of fastest-growing brands among GLP-1 users in 2023